Pharmacokinetic characteristics of therapeutic antibodies. - Wikidata - awgldk - TriplyDB

Pharmacokinetic characteristics of therapeutic antibodies.

Pharmacokinetic characteristics of therapeutic antibodies.

http://www.wikidata.org/entity/Q30316517

about

Quantification of IgG monoclonal antibody clearance in tissues.Considerations for dosing immunoglobulin in obese patients.

P2860

Q38726179-CA247986-E1F6-4EED-81B9-C78BB42DED21 Q39163785-3F219D99-56CC-4F6C-B60F-C4FF26E04423

P2860

Pharmacokinetic characteristics of therapeutic antibodies.

http://www.wikidata.org/entity/Q30316517

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Pharmacokinetic characteristics of therapeutic antibodies.

@ast

Pharmacokinetic characteristics of therapeutic antibodies.

@en

type

label

Pharmacokinetic characteristics of therapeutic antibodies.

@ast

Pharmacokinetic characteristics of therapeutic antibodies.

@en

prefLabel

Pharmacokinetic characteristics of therapeutic antibodies.

@ast

Pharmacokinetic characteristics of therapeutic antibodies.

@en

P1433

Q30316517-6FA4D7A7-8347-4E8C-9331-6C044FD93183

P1476

Q30316517-9577EFA8-31CF-400D-8143-7FBD1206412D

P2093

Q30316517-05A8B255-0B6A-4FAB-8AEE-5744E6F07A81

P2860

Q30316517-1791D36A-689A-405C-AA53-8D4AB091FA57

Q30316517-18B6763B-A63C-441D-89FB-330123AFBAC5

Q30316517-218847BB-7562-4CE3-8F0C-EE859E4C2A8E

Q30316517-337B6EB2-073D-4D7A-8677-74173C150172

Q30316517-4B0F988E-7837-47B3-9840-D6759CBC701B

Q30316517-4BA1E9A5-A800-4F15-8B2A-98ABF7599187

Q30316517-4FE7F8A6-8E30-4372-ADBB-38670FB2A27E

Q30316517-709EF23E-03C3-4C3E-B29D-E20E33F0BA70

Q30316517-8F52C25F-4FB8-4C67-BFA7-AF4CE76BFA4B

Q30316517-94F99730-6A3C-46B7-B465-6A2F567DA7DA

P304

Q30316517-14B8128A-8985-4E57-AFFE-393209463284

P31

Q30316517-787C4ADB-F78E-41D3-919D-8125C9DA13F2

P356

Q30316517-ADD1F567-7670-4581-A0DA-07A0F1B56BBB

P433

Q30316517-D9FA69E9-525F-4F69-945B-4BC3C4EBB07B

P478

Q30316517-6168237D-50FE-4BAB-9E1D-43936056B3F9

P577

Q30316517-FDD87F45-23F9-4E26-B2C8-9182E5D5222A

P698

Q30316517-FDE8CCE8-C29A-48EA-80E9-12A851681898

P921

Q30316517-5DDB2EAB-E541-418E-B2AE-266A375922B8

P356

DDG.12648_SUPPL

P1433

P1476

Pharmacokinetic characteristics of therapeutic antibodies.

@en

P2093

Johannes Wohlrab

http://www.w3.org/2001/XMLSchema#string

P2860

Biologics in dermatology: an integrated review

Population pharmacokinetics of sibrotuzumab, a novel therapeutic monoclonal antibody, in cancer patients

High interstitial fluid pressure - an obstacle in cancer therapy

Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.

Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjects.

Immunogenicity of therapeutic proteins: clinical implications and future prospects.

Metabolic properties of IgG subclasses in man.

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease.

Pharmacokinetics and concentration-effect relationships of therapeutic monoclonal antibodies and fusion proteins.

Development and production of commercial therapeutic monoclonal antibodies in Mammalian cell expression systems: an overview of the current upstream technologies.

P304

530-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DDG.12648_SUPPL

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26018364

http://www.w3.org/2001/XMLSchema#string

P921

pharmacokinetics